Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
Authors
Keywords
-
Journal
Brain and Behavior
Volume -, Issue -, Pages e01312
Publisher
Wiley
Online
2019-05-07
DOI
10.1002/brb3.1312
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
- (2019) Alex Molassiotis et al. BMC CANCER
- Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors
- (2018) Christine Miaskowski et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Chemotherapy-Induced Neuropathy in Cancer Survivors
- (2017) Christine Miaskowski et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice
- (2017) Natalie B. Simon et al. QUALITY OF LIFE RESEARCH
- Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey
- (2017) J . Matt McCrary et al. SUPPORTIVE CARE IN CANCER
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
- (2016) Ting Bao et al. BREAST CANCER RESEARCH AND TREATMENT
- Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials
- (2016) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study
- (2016) Heather Greenlee et al. JNCI-Journal of the National Cancer Institute
- Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy
- (2016) Alessandro Ottaiano et al. ONCOLOGY
- BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study
- (2016) Heather Greenlee et al. JNCI-Journal of the National Cancer Institute
- Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
- (2015) L. Eckhoff et al. EUROPEAN JOURNAL OF CANCER
- Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study
- (2015) Mark A. Lewis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study
- (2015) Susana Pereira et al. SUPPORTIVE CARE IN CANCER
- Mechanisms of chemotherapy-induced behavioral toxicities
- (2015) Elisabeth G. Vichaya et al. Frontiers in Neuroscience
- Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry
- (2014) Nicole P.M. Ezendam et al. GYNECOLOGIC ONCOLOGY
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
- (2014) Floortje Mols et al. SUPPORTIVE CARE IN CANCER
- Should we adjust for a confounder if empirical and theoretical criteria yield contradictory results? A simulation study
- (2014) Paul H. Lee Scientific Reports
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation
- (2012) Karima Osmani et al. JOURNAL OF NEUROLOGY
- Factors Exacerbating Peripheral Neuropathy Induced by Paclitaxel Plus Carboplatin in Non-small Cell Lung Cancer
- (2012) Kazuyoshi Kawakami et al. ONCOLOGY RESEARCH
- Therapy of chemotherapy-induced peripheral neuropathy
- (2009) Thomas J. Kaley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer
- (2008) C. Wan et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started